Trials of embryonic stem cells to launch in China

Trials of embryonic stem cells to launch in China

Jason Lee/Reuters In the next few months, surgeons in the Chinese city of Zhengzhou will carefully drill through the skulls of people with Parkinson’s disease and inject 4 million immature neurons derived from human embryonic stem cells into their brains. Then they will patch the patients up, send them home and wait.

Written by 

June 2013 – Present: Program Manager, Memorial Sloan-Kettering Cancer Center July 2009 – June 2012: iPierian, Senior Scientist & Project Team Leader January 2007 – June 2009: Postdoctoral fellow, University Health Network October 2003 – December 2006: Postdoctoral fellow, Mount Sinai School of Medicine